LEARNER OBJECTIVES
At the completion of this chapter, the learner will be able to:
Section 1: Introduction
1.0 Give the incidence of HIV in Canada.
Section 2: Basic
Principles of HIV Infection
2.0 Describe the etiology of HIV infection.
2.1 Discuss the process to determine if patients are of high risk
for
acquiring HIV infection,
including sexual orientation, sexual practices,
history of other sexually
transmitted diseases and intravenous drug use.
2.2 Describe how to diagnose HIV infection.
2.3 List the common antiretroviral drugs used in the treatment of
HIV infection.
Section 3: Gastrointestinal Involvement in HIV Infection
3.1 General Considerations
3.1.0 Discuss the issues that
must be considered in the evaluation of
HIV-positive patients with
gastrointestinal symptoms.
3.2 Bacterial Infections
3.2.0 Describe the principles of
treatment for acute bacterial enteritis
or colitis in HIV-infected
patients.
3.2.1 Explain the treatment
regimens for HIV-related gastrointestinal
infections.
3.3 Mycobacterial Infections
3.3.1 Describe Mycobacterium
avium-intracellulare (MAI) as related to
immunocompromised HIV-infected
patients.
3.4 Fungal Infections
3.4.1 Explain the clinical
presentation, diagnosis, and treatment protocol for
candidal esophagitis.
3.4.2 List other fungal
infections seen in HIV infection.
3.5 Intestinal Parasitic Infections
3.5.0 Describe the following
intestinal parasitic infections, including
symptoms, diagnosis, and
treatment as related to HIV-infected patients.
3.5.1 Giardiasis
3.5.2 Entamoeba histolytica
3.5.3 Cryptosporidium
3.5.4 Microsporidium
3.5.5 Isospora belli
3.5.6 Strongyloides stercoralis
3.6 Viral Infections
3.6.0 Describe the following
viral infections, including presentation,
diagnosis, and treatment as
related to HIV-infected patients.
3.6.1 Cytomegalovirus
3.6.2 Herpes simplex virus
3.7 Neoplasms
3.7.0 Describe the following
neoplasms, including presentation,
diagnosis, and treatment as
related to HIV-infected patients.
3.7.1 Kaposi's sarcoma
3.7.2 Lymphoma
3.7.3 Anal carcinoma
Section 4: Hepatobiliary and Pancreatic Involvement in HIV
Infection
4.0 Discuss the involvement of the liver in HIV infection, including
hepatitis B and C.
4.1 Discuss biliary involvement in HIV infection.
4.2 Discuss symptomatic pancreatic involvement in HIV infection.
Section 5: Nutritional Considerations and the Wasting Syndrome
5.0 Describe the cause of weight loss in HIV-infected patients.
5.1 Discuss treatment protocols for wasting.
LEARNER WORKBOOK
EXERCISE 1
1.1 What is HIV?
1.1.1 Briefly describe the
etiology of HIV infection.
Answer
(section 2, p288-289)
2.1 Explain the process to determine if a
patient is at high risk of acquiring HIV
infection.
Answer
(section 2, p289)
2.2 How is AIDS diagnosed?
Answer
(section 2, p289)
2.3 List five common antiretroviral drugs used
in the treatment of HIV infection.
Answer
(section 2, p289)
EXERCISE 2
3.1 Briefly discuss the issues that must be considered in the
evaluation of
HIV-positive patients with
gastrointestinal symptoms.
Answer
(section 3.1, p290)
3.2 What is Mycobacterium
avium-intracellulare (MAI)?
3.2.1 What are the presenting
symptoms?
Answer
(section 3.3.1, p291)
3.3 Fill in the following chart:
| Treatment
regimens for HIV-related gastrointestinal infections: |
Organism Drug
of First Choice Alternative
Treatments
Salmonella
Shigella
Mycobacterium
tuberculosis
Candida albicans
(esophageal)
Histoplasmosis
Cryptosporidium
Herpes simplex virus
Cytomegalovirus
|
Answer
( table 1, p292-293)
3.4 How is candidal esophagitis diagnosed?
Answer
(section 3.4.1, p294)
3.5 Briefly describe Giardia lamblia and
Entamoeba histolytica infection in
HIV-infected patients.
Answer
(section 3.5, p296)
3.6 How does cytomegalovirus infection
present in patients with HIV infection?
3.6.1 How is CMV treated?
Answer
(section 3.6.1, p299)
3.7 What is the most common neoplasm seen
in HIV-infected patients?
Answer
(section 3.7.1, p301)
4.1 How is the liver affected in
HIV-infected patients?
Answer
(section 4, p302-303)
5.1 What are the causes of weight loss in
HIV-infected patients?
Answer
(section 5, p304, paragraph 1)
5.2 What are the treatments for
HIV-associated wasting?
Answer
(section 5, p304, paragraph 2)